Filing Details
- Accession Number:
- 0001652252-19-000051
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-09 17:50:09
- Reporting Period:
- 2019-09-05
- Accepted Time:
- 2019-09-09 17:50:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 12208 | Bio-Rad Laboratories Inc. | BIO, BIOB | Laboratory Analytical Instruments (3826) | 941381833 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1616003 | John Hertia | C/O Bio-Rad Laboratories, Inc. 1000 Alfred Nobel Drive Hercules CA 94547 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Rad A Common Stock | Acquisiton | 2019-09-05 | 600 | $0.00 | 15,507 | No | 4 | M | Direct | |
| Bio-Rad A Common Stock | Disposition | 2019-09-05 | 208 | $339.48 | 15,299 | No | 4 | F | Direct | |
| Bio-Rad A Common Stock | Acquisiton | 2019-09-06 | 2,400 | $119.54 | 17,699 | No | 4 | M | Direct | |
| Bio-Rad A Common Stock | Acquisiton | 2019-09-06 | 1,800 | $139.56 | 19,499 | No | 4 | M | Direct | |
| Bio-Rad A Common Stock | Acquisiton | 2019-09-06 | 1,200 | $159.32 | 20,699 | No | 4 | M | Direct | |
| Bio-Rad A Common Stock | Acquisiton | 2019-09-06 | 1,200 | $215.98 | 21,899 | No | 4 | M | Direct | |
| Bio-Rad A Common Stock | Acquisiton | 2019-09-06 | 600 | $326.15 | 22,499 | No | 4 | M | Direct | |
| Bio-Rad A Common Stock | Disposition | 2019-09-06 | 700 | $334.77 | 21,799 | No | 4 | S | Direct | |
| Bio-Rad A Common Stock | Disposition | 2019-09-06 | 1,871 | $335.64 | 19,928 | No | 4 | S | Direct | |
| Bio-Rad A Common Stock | Disposition | 2019-09-06 | 1,231 | $336.80 | 18,697 | No | 4 | S | Direct | |
| Bio-Rad A Common Stock | Disposition | 2019-09-06 | 750 | $338.01 | 17,947 | No | 4 | S | Direct | |
| Bio-Rad A Common Stock | Disposition | 2019-09-06 | 543 | $338.97 | 17,404 | No | 4 | S | Direct | |
| Bio-Rad A Common Stock | Disposition | 2019-09-06 | 100 | $340.00 | 17,304 | No | 4 | S | Direct | |
| Bio-Rad A Common Stock | Acquisiton | 2019-09-07 | 600 | $0.00 | 17,904 | No | 4 | M | Direct | |
| Bio-Rad A Common Stock | Disposition | 2019-09-07 | 298 | $335.59 | 17,606 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Bio-Rad A Common Stock | Restricted Stock Units | Disposition | 2019-09-05 | 600 | $0.00 | 600 | $0.00 |
| Bio-Rad A Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-09-06 | 2,400 | $0.00 | 2,400 | $119.54 |
| Bio-Rad A Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-09-06 | 1,800 | $0.00 | 1,800 | $139.56 |
| Bio-Rad A Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-09-06 | 1,200 | $0.00 | 1,200 | $159.32 |
| Bio-Rad A Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-09-06 | 1,200 | $0.00 | 1,200 | $215.98 |
| Bio-Rad A Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-09-06 | 600 | $0.00 | 600 | $326.15 |
| Bio-Rad A Common Stock | Restricted Stock Units | Disposition | 2019-09-07 | 600 | $0.00 | 600 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,800 | No | 4 | M | Direct | ||
| 600 | 2024-09-10 | No | 4 | M | Direct | |
| 1,200 | 2025-09-11 | No | 4 | M | Direct | |
| 1,800 | 2026-09-07 | No | 4 | M | Direct | |
| 1,800 | 2027-09-05 | No | 4 | M | Direct | |
| 2,400 | 2028-09-04 | No | 4 | M | Direct | |
| 1,200 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Bio-Rad A Common Stock | 252 | Indirect | By Spouse |
Footnotes
- Shares of Class A common stock acquired on the vesting of restricted stock units.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $334.29 to $335.22, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.32 to $336.24, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $336.36 to $337.20, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $337.63 to $338.44, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $338.63 to $339.17, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- The restricted stock units vest in five equal annual installments beginning September 5, 2018.
- The option vests in five equal annual installments beginning September 10, 2015.
- The option vests in five equal annual installments beginning September 11, 2016.
- The option vests in five equal annual installments beginning September 7, 2017.
- The option vests in five equal annual installments beginning September 5, 2018.
- The option vests in five equal annual installments beginning September 4, 2019.
- The restricted stock units vest in five equal annual installments beginning September 7, 2017.
Billionaire Hedge Funds
